Outcome | At 20Â weeks | Mean change from baseline | |||
---|---|---|---|---|---|
Questionnaire | TFCBT (n = 16) | RTM (n = 29) | TFCBT (n = 16) | RTM (n = 29) | Difference in means (RTM vs TF-CBT), 95% CI |
PCL-5, mean (SD) | 48.31 (11.98) | 38.17 (17.70) | − 8.38(− 15.60 to − 1.15) | − 17.71 (− 25.80 to − 9.63) | − 9.34 (− 21.39 to 2.71) |
Percentage met PCL MCID, % (95% CI) | 16.00 (5.82 to 37.00) | 48.47 (32.30 to 65.25) | – | – | – |
WSAS, mean (SD) | 23.00 (9.61) | 19.07 (11.50) | − 3.06 (− 7.21 to 1.09) | − 4.62 (− 8.05 to − 1.19) | − 1.56 (− 7.11 to 4.00) |
Percentage met WSAS MCID, % (95% CI) | 24.00 (10.72 to 45.36) | 25.71 (13.62 to 43.17) | – | – | – |
QPR, mean (SD) | 42.94 (9.56) | 46.76 (13.14) | − 2.38 (− 8.26 to 3.51) | 1.66 (− 3.62 to 6.93) | 4.03 (− 4.33 to 12.39) |
PHQ-9, mean (SD) | 17.25 (4.80) | 15.18 (7.51) | − 3.07 (− 6.27 to 0.13) | − 2.73 (− 5.43 to − 0.04)) | 0.34 (− 3.86 to 4.50) |
Percentage met PHQ-9 MCID, % (95% CI) | 24.00 (10.72 to 45.36) | 20.00 (9.58 to 37.11) | – | – | – |
GAD-7, mean (SD) | 13.50 (4.12) | 11.82 (6.09) | − 3.43 (− 6.84 to − 0.02) | − 3.11 (− 5.54 to 0.68) | 0.32 (− 3.86 to 4.50) |
Percentage met GAD-7 MCID, % (95% CI) | 24.00 (10.72 to 45.35) | 22.86 (11.56 to 40.17) | – | – | – |
EQ VAS, mean (SD) | 50.06 (21.94) | 57.14 (25.15) | 0.06 (− 15.81 to 15.93) | 5.66 (− 4.35 to 15.66) | 5.59 (− 12.30 to 23.48) |